Global Information
회사소개 | 문의 | 비교리스트

치료용 백신 시장(2020-2026년)

Therapeutic Vaccine Market 2020-2026 2020-2026

리서치사 Orion Market Research Pvt Ltd
발행일 2020년 06월 상품 코드 949647
페이지 정보 영문
가격
US $ 3,600 ₩ 4,252,000 Unprintable PDF (Single User License)
US $ 4,800 ₩ 5,670,000 Printable PDF (Enterprise License)


치료용 백신 시장(2020-2026년) Therapeutic Vaccine Market 2020-2026 2020-2026
발행일 : 2020년 06월 페이지 정보 : 영문

세계 치료용 백신 시장은 예측기간 중 대폭 성장할 예정입니다. 치료용 백신은 일반적으로 감염증이나 질병이 신체를 억제한 후에 일반적으로 사용됩니다. 시장 성장에 기여하는 주요인에는 백신 적용 범위를 확대하기 위한 치료용 백신에 관련된 연구개발 활동 확대가 있으며, 이것이 세계 치료용 백신 시장 성장을 가속하고 있습니다. 자가면역질환 백신이 높은 시장 점유율을 획득할 전망입니다.

지리적으로는 아시아태평양이 예측기간 중 세계 치료용 백신 시장에서 높은 성장률을 나타낼 것으로 예측됩니다. 헬스케어 인프라 개선은 시장의 지역적인 성장을 한층 더 뒷받침할 것입니다. 북미는 시장에서 높은 점유율을 차지할 것으로 예상되고 있습니다. 북미의 성장은 새로운 첨단 치료용 백신의 요건을 충족시키는 충분히 개발된 헬스케어 및 연구개발 부문에 의한 것입니다.

세계의 치료용 백신(Therapeutic Vaccine) 시장에 대해 조사했으며, 시장 개요, 제품별·기술별·지역별 동향, 경쟁 동향 및 시장 진출기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 보고서 개요

제2장 시장 개요와 인사이트

  • 조사 범위
  • 애널리스트 인사이트와 현재 시장 동향
  • 규칙과 규제

제3장 경쟁 구도

  • 주요 전략 분석
  • 주요 기업 분석
    • Agenus Inc.
    • GlaxoSmithKline plc
    • Merck&Co., Inc.
    • Novartis International AG
    • Pfizer Inc.

제4장 시장 결정요인

  • 동기
  • 억제요인
  • 시장 기회

제5장 시장 세분화

  • 제품별 시장
    • 자가면역질환 백신
    • 신경질환 백신
    • 암 백신
    • 감염증 백신
    • 기타
  • 기술별 시장
    • 동종 백신
    • 자가 백신

제6장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 스페인
    • 프랑스
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 기타
  • 기타 지역

제7장 기업 개요

  • Affiris AG
  • Agenus Inc.
  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • BioNTech SE
  • CuraVac AG
  • Eli Lilly and Co.
  • Epivax Oncology Inc.
  • Flow Pharma, Inc.
  • GlaxoSmithKline plc
  • Heat Biologics, Inc.
  • ImmusanT, Inc.
  • Inhibikase Therapeutics, Inc.
  • Intervexion Therapeutics
  • Mercia Pharma Inc.
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • Shanghai Fosun Pharma(Group) Co., Ltd.
  • Transgene SA
  • Vaccibody AS
  • Vaxinano SE
LSH 20.08.06

LIST OF TABLES

  • 1. GLOBAL THERAPEUTICS VACCINE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2019-2026 ($ MILLION)
  • 2. GLOBAL AUTOIMMUNE DISEASE VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL NEUROLOGICAL DISEASE VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. GLOBAL CANCER VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 5. GLOBAL INFECTIOUS DISEASE VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 6. GLOBAL OTHER THERAPEUTICS VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL THERAPEUTICS VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2019-2026 ($ MILLION)
  • 8. GLOBAL ALLOGENEIC VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 9. GLOBAL AUTOLOGOUS VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 10. GLOBAL THERAPEUTICS VACCINE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 11. NORTH AMERICAN THERAPEUTICS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 12. NORTH AMERICAN THERAPEUTICS VACCINE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2019-2026 ($ MILLION)
  • 13. NORTH AMERICAN THERAPEUTICS VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2019-2026 ($ MILLION)
  • 14. EUROPEAN THERAPEUTICS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 15. EUROPEAN THERAPEUTICS VACCINE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2019-2026 ($ MILLION)
  • 16. EUROPEAN THERAPEUTICS VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2019-2026 ($ MILLION)
  • 17. ASIA-PACIFIC THERAPEUTICS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 18. ASIA-PACIFIC THERAPEUTICS VACCINE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2019-2026 ($ MILLION)
  • 19. ASIA-PACIFIC THERAPEUTICS VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2019-2026 ($ MILLION)
  • 20. REST OF THE WORLD THERAPEUTICS VACCINE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2019-2026 ($ MILLION)
  • 21. REST OF THE WORLD THERAPEUTICS VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL THERAPEUTICS VACCINE MARKET SHARE BY PRODUCT, 2019 VS 2026 (%)
  • 2. GLOBAL THERAPEUTICS VACCINE MARKET SHARE BY TECHNOLOGY, 2019 VS 2026 (%)
  • 3. GLOBAL THERAPEUTICS VACCINE MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 4. US THERAPEUTICS VACCINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. CANADA THERAPEUTICS VACCINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. UK THERAPEUTICS VACCINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. FRANCE THERAPEUTICS VACCINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. GERMANY THERAPEUTICS VACCINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. ITALY THERAPEUTICS VACCINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. SPAIN THERAPEUTICS VACCINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. ROE THERAPEUTICS VACCINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. INDIA THERAPEUTICS VACCINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. CHINA THERAPEUTICS VACCINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. JAPAN THERAPEUTICS VACCINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC THERAPEUTICS VACCINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF THE WORLD THERAPEUTICS VACCINE MARKET SIZE, 2019-2026 ($ MILLION)

Therapeutic Vaccine Market Size, Share & Trends Analysis Report by Product (Autoimmune Disease Vaccines, Neurological Disease Vaccines, Cancer Vaccines, Infectious Disease Vaccines and Others), By Technology (Allogeneic Vaccine and Autologous Vaccine), and Forecast 2020-2026

The global therapeutic vaccine market is anticipated to grow significantly during the forecast period. Therapeutics vaccine are generally used after the infection or disease has curbed the body. The major factor contributing to the growth of the market include increasing R&D activity related to therapeutic vaccine to broadening the scope of vaccine is, which in turn, driving the global therapeutic vaccine market.

The therapeutic vaccine market is segmented on the basis of the product and technology. Based on the product, the market is sub-segmented into autoimmune disease vaccines, neurological disease vaccines, cancer vaccines, infectious disease vaccines, and others. Autoimmune disease vaccines is expected to hold significant market share. Further, based on the technology, the market is bifurcated into the allogeneic vaccine and autologous vaccine.

Geographically, the study of the global therapeutic vaccine market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global therapeutic vaccine market during the forecast period. The improving healthcare infrastructure further gives a boost to the regional growth of the market. North America is expected to hold significant share in the market. The growth in the region is due to the well-developed healthcare and R&D sector that caters the requirement of new and advanced therapeutic vaccines.

Moreover, the study of the global therapeutic vaccine market report covers the analysis of various players operating in the market. Some of the key players covered in the report include Agenus Inc., GlaxoSmithKline plc, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Sanofi SA, Eli Lilly and Co., and others. The market players are considerably contributing to the market growth by adopting various strategies including merger, and acquisition, collaborations with government, funding, and various advancements in the R&D to stay competitive in the market. For instance, in February 2019, Merck & Co. Inc. acquired Immune Design and its cancer vaccines platform in a deal of total $300 million.

Research Methodology

The market study of the global therapeutic vaccine market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for the pharmaceutical industry, drug manufacturers, vaccine manufacturers, hospitals & clinics, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, market determinants, and future market growth. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. Global Therapeutic Vaccine Market Research and Analysis by Product

2. Global Therapeutic Vaccine Market Research and Analysis by Technology

The Report Covers:

  • Comprehensive research methodology of the global therapeutic vaccine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global therapeutic vaccine market.
  • Insights about market determinants which are stimulating the global therapeutic vaccine market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Key Strategy Analysis
  • 3.2. Key Company Analysis
    • 3.2.1. Agenus Inc.
      • 3.2.1.1. Overview
      • 3.2.1.2. Financial Analysis
      • 3.2.1.3. SWOT Analysis
      • 3.2.1.4. Recent Developments
    • 3.2.2. GlaxoSmithKline plc
      • 3.2.2.1. Overview
      • 3.2.2.2. Financial Analysis
      • 3.2.2.3. SWOT Analysis
      • 3.2.2.4. Recent Developments
    • 3.2.3. Merck & Co., Inc.
      • 3.2.3.1. Overview
      • 3.2.3.2. Financial Analysis
      • 3.2.3.3. SWOT Analysis
      • 3.2.3.4. Recent Developments
    • 3.2.4. Novartis International AG
      • 3.2.4.1. Overview
      • 3.2.4.2. Financial Analysis
      • 3.2.4.3. SWOT Analysis
      • 3.2.4.4. Recent Developments
    • 3.2.5. Pfizer Inc.
      • 3.2.5.1. Overview
      • 3.2.5.2. Financial Analysis
      • 3.2.5.3. SWOT Analysis
      • 3.2.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Therapeutics Vaccine Market by Product
    • 5.1.1. Autoimmune Disease Vaccines
    • 5.1.2. Neurological Disease Vaccines
    • 5.1.3. Cancer Vaccines
    • 5.1.4. Infectious Disease Vaccines
    • 5.1.5. Other
  • 5.2. Global Therapeutics Vaccine Market by Technology
    • 5.2.1. Allogeneic Vaccine
    • 5.2.2. Autologous Vaccine

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Affiris AG
  • 7.2. Agenus Inc.
  • 7.3. AstraZeneca PLC
  • 7.4. Bavarian Nordic A/S
  • 7.5. BioNTech SE
  • 7.6. CuraVac AG
  • 7.7. Eli Lilly and Co.
  • 7.8. Epivax Oncology Inc.
  • 7.9. Flow Pharma, Inc.
  • 7.10. GlaxoSmithKline plc
  • 7.11. Heat Biologics, Inc.
  • 7.12. ImmusanT, Inc.
  • 7.13. Inhibikase Therapeutics, Inc.
  • 7.14. Intervexion Therapeutics
  • 7.15. Mercia Pharma Inc.
  • 7.16. Merck & Co., Inc.
  • 7.17. Moderna, Inc.
  • 7.18. Novartis International AG
  • 7.19. Pfizer Inc.
  • 7.20. Sanofi SA
  • 7.21. Shanghai Fosun Pharma (Group) Co., Ltd.
  • 7.22. Transgene SA
  • 7.23. Vaccibody AS
  • 7.24. Vaxinano SE
Back to Top
전화 문의
F A Q